Heparan sulfates (HSs) are extraordinarily complex extracellular sugar molecules that are critical components of multiple signaling systems controlling neuronal development [1] [2] [3] . The molecular complexity of HSs arises through a series of specific modifications, including sulfations of sugar residues and epimerizations of their glucuronic acid moieties. The modifications are introduced nonuniformly along protein-attached HS polysaccharide chains by specific enzymes [4] . Genetic analysis has demonstrated the importance of specific HS-modification patterns for correct neuronal development [2, 3] . However, it remains unclear whether HS modifications provide a merely permissive substrate or whether they provide instructive patterning information during development. We show here with single-cell resolution that highly stereotyped motor axon projections in C. elegans depend on specific HS-modification patterns. By manipulating extracellular HS-modification patterns, we can cell specifically reroute axons, indicating that HS modifications are instructive. This axonal rerouting is dependent on the HS core protein lon-2/glypican and both the axon guidance cue slt-1/Slit and its receptor eva-1. These observations suggest that a changed sugar environment instructs slt-1/Slitdependent signaling via eva-1 to redirect axons. Our experiments provide genetic in vivo evidence for the ''HS code'' hypothesis which posits that specific combinations of HS modifications provide specific and instructive information to mediate the specificity of ligand/receptor interactions [3, 5, 6] .
Results

Distinct HS-Modification Patterns Are Required by Individual Ventral Cord Motor Neurons for Correct Axon Pathfinding
The DA and DB classes of motor neurons are embryonically generated motor neurons (eMNs) in the ventral nerve cord (VNC) of C. elegans. Individual DA and DB motor neurons make differential, completely invariant choices as to whether to extend circumferentially along the right or left side of the animal ( Figures 1B-1D ). This sidedness does not correlate with the membership of a motor neuron to a specific class (e.g., two DA neurons extend along the right side, and seven DA neurons extend to the left side; Table S1 available online), nor position along the a/p axis ( Figure 1B ; Table S1 ), lineage history (Table S1 ), or any other unique cellular landmark in their environment (Table S1 ). Intriguingly, there are no molecular markers that distinguish individual DA neurons or individual DB neurons from one another (i.e., no genes are known that are expressed in DB2 but not DB3) and no genes have been reported that control the cell-type specificity of the projection patterns. To test whether individual DA/DB motor neurons require distinct HS modifications for correct development, we genetically removed three major HS-modifying enzymes, the C5-epimerase encoded by hse-5, the 6O-sulfotransferase encoded by hst-6, and the 2O-sulfotransferase, encoded by hst-2 ( Figures 1A and 1E ). Because none of these enzymes have paralogs in C. elegans, we can assume that animals with null mutations in these genes completely lack C5-epimerization, 6O-sulfation, or 2O-sulfation [7] . Removal of C5-epimerization or 2O-sulfation each result in mild defects in the sidedness of motor axon projections [7] . These mild defects show cell-type specificity, with DA2, DB3, DB6, and DB7 being most affected by loss of 2O-sulfation ( Figure 1E ). Generation of double mutants as well as a triple mutant resulted in significantly enhanced mutant phenotypes, revealing cell-type-specific redundancies in the requirement of HS modifications for individual motor axons ( Figure 1F ). For example, the DA2, DB3, and DB6 motor neurons display significantly enhanced defects in the hst-6 hst-2 and hse-5; hst-6 double mutant combinations, indicating that hst-6 function is redundant with both hse-5 and hst-2 in these motor neurons. However, in DA6 motor neurons, hst-6 function is redundant with hse-5 but not with hst-2, whereas, in DB5 motor neurons, hst-6 is redundant with hst-2 but not with hse-5 ( Figure 1F ). The HS-modification enzymes hst-6 and hst-2/hse-5 appear to act in different tissues during neuronal development, with hst-6 acting in neuronal tissues and hse-5/hst-2 in hypodermal tissues [7] . Thus, the observation that hst-6 and hse-5/hst-2 serve redundant functions in some neurons may seem nonintuitive given their disparate sites of action. However, HS has been demonstrated to act cell nonautonomously in, for example, ectodermal/mesodermal interactions [8] . It is therefore conceivable that differentially modified HS on neuronal and hypodermal tissues cooperate in a redundant manner to control axon routing.
In contrast, the defects in hse-5; hst-2 double mutants are no more severe than the defects in the most severe (hst-2) of the single mutants ( Figure 1F ). This last finding is consistent with analyses in other cellular contexts that demonstrate that hse-5 and hst-2 can genetically act in the same pathway [7] . Finally, no further enhancement is observed in the triple mutant combination compared to the hst-6 hst-2 double null mutant ( Figure 1F ). We conclude that individual members of the same class of motor neurons (DA or DB) that make apparently identical guidance choices at the ventral midline of C. elegans are dependent on different combinations of HS modifications.
Removal of the HS core protein syndecan (sdn-1) recapitulates the defects observed in hse-5; hst-6 hst-2 triple mutants, both in terms of penetrance and cell-type specificity ( Figures  1E and 1F) . In contrast, neither null mutations in the two C. elegans glypican HS core proteins (gpn-1 and lon-2; [9, 10] ) nor mutations in the secreted HS core proteins unc-52 (perlecan; [11] ) or cle-1 (collagen XVIII; [12] ) display significant defects in eMN left/right projection patterns ( Figure S1A ). These results suggest that the majority of HS that controls DA/DB motor axon choices may be attached to the syndecan core protein. Table S1 for a systematic comparison of individual motor neuron class members. (C) Visualizing the DA and DB motor axons with an unc-129::gfp-expressing transgene. (D) The left/right asymmetric, circumferential DA, DB axon projection patterns are highly stereotyped. We focus our scoring on the DA2 to DA6 and DB3 to DB7 motor neurons because those express the gfp reporter transgene most reliably. ''% defect.'' indicates percentage of animals with a defective sidedness of the respective DA or DB axon as indicated. (E) Loss of HS modifications affect DA and DB axon choices in a cell-type-specific manner. All mutants used are null mutants [7, 31] . Single mutants were statistically compared to wild-type (see [D] ); ns, not significantly different; *p < 0.05, **p < 0.005. (F) Comparison of effects of single, double, and triple HS mutants on specific motor axons. Double mutants were statistically compared to the more severe of two respective single mutants; ns, not significantly different; *p < 0.05, **p < 0.005, ***p < 0.0005. The defects in both DA2 and DB3 are weakly statistically significant when comparing the triple hse-5; hst-6 hst-2 mutant and the sdn-1/syndecan null mutant (p = 0.04 and 0.03, respectively). However, these differences are not significant between the hst-6 hst-2 double mutant and either the sdn-1/syndecan mutant or the hse-5; hst-6 hst-2 triple mutant, suggesting that the phenotype of the sdn-1 and the hse-5; hst-6 hst-2 triple mutant is very similar. Error bars denote the standard error of proportion. See Experimental Procedures for statistics. Note that unlike in larvae, the embryonic midline, defined as a physical barrier between the left and right ventral fascicles, is not constituted by a hypodermal evagination but by motor neuron cell bodies [32] .
Manipulating HS-Modification Patterns Redirect Motor Axon Projections
Our present work with DA/DB motor neurons together with previous work shows that the function of HS requires their extensively modified polysaccharide chains ( Figure 1A ; reviewed in [3, 13] ). However, it is unclear whether HS modifications constitute a merely permissive environment or whether they are sufficient to guide growing axons. The question of permissiveness versus instructiveness represents one of the key problems in the HS field [3, 13] .
To address whether HS modifications are sufficient to guide axons, i.e., serve instructive functions, we manipulated HS-modification patterns by inducing ectopic 6O-sulfation in the hypodermal cells that underlie the DA/DB motor neurons ( Figure 2A ). The 6O-sulfotransferase hst-6 does not appear to be expressed in hypodermal cells [7] (Figure 2A ) and as shown above, DA/DB axon choices are unaffected by removal of hst-6 alone ( Figure 1E ). To alter HS-modification patterns presented by hypodermal cells, we generated multiple transgenic C. elegans lines that aberrantly express hst-6 in an otherwise wild-type background under control of the hypodermisspecific dpy-7 promoter [14] . Worms expressing this construct show an altered status of HS-modification patterns. First, we detect novel staining patterns with an antibody that recognizes HS epitopes comprising specific oligosaccharides rather than individual modifications ( Figure 2B ) [15] . This antibody labels the anterior intestine and possibly some neurons and basement membranes in wild-type animals (not shown). However, increased staining is observed consistently in the hypodermis upon misexpression of hst-6 in this tissue. This increased staining pattern is not observed in nontransgenic but otherwise isogenic controls ( Figure 2B ). And second, biochemical analyses of HS from transgenic worms expressing hst-6 in the hypodermis display an increase of 6O-sulfated relative to 2O-sulfated HS disaccharides ( Figure S2 ). Each transgenic line shows a significant number of animals in which the projections of individual DA and DB motor neurons are rerouted (Figures 2C and 3A ; Figure S3 ). These defects are not the result of apparent changes in cell fate or structure of hypodermal cells misexpressing hst-6 ( Figure 2E ), nor are they due to changes in eMN positioning in the VNC (data not shown). Moreover, we cannot detect obvious disruptions of the basement membranes surrounding eMNs and therefore consider it unlikely that ectopic hst-6 expression grossly disrupts midline structures ( Figure 2F) .
The axonal misrouting defects we observe are the result of hst-6 activity as the introduction of a premature stop codon into the hst-6 expression construct abolishes its ability to induce axon misrouting ( Figure 3A) . Furthermore, no comparable misrouting defects can be observed upon dpy-7 prom -driven overexpression of the HS 2O-sulfotransferase hst-2 ( Figure 3A) , which is normally expressed in both neuronal and hypodermal tissues [7] . These hst-2 expressing transgenes are functional: First, the transgenes are able to effectively rescue neuronal hst-2 loss-of-function phenotypes ( Figure S4A) ; second, by using an antibody recognizing specific HS epitopes, we detect increased staining in transgenic, hst-2-overexpressing strains ( Figure S4B) ; third, biochemical analyses of hst-2-overexpressing strains display increased 2O-sulfation relative to 6O-sulfation compared to wild-type ( Figure S2 ). Together, our results argue that the effects of ectopic hst-6 expression are due to the regiospecific addition of a sulfate moiety to the 6O-hydroxyl group of the glucosamine residue, rather than the unspecific addition of a negative charge.
Examining the axon choices of individual DA and DB motor axons, we find that the defects induced by ectopic 6O-sulfation are cell-type specific with all different transgenic lines displaying qualitatively similar misrouting patterns. Interestingly, there seems to be a graded response of DB neurons to misexpressed hst-6, with the more posterior neurons being more strongly affected ( Figure 3C ; Figure S3 ). In contrast, within the DA class of eMNs, only DA3 exhibits significant defects. Ectopic hypodermal 6O-sulfation also causes axon guidance defects in a selected number of other neurons in the nervous system. For example, axon midline guidance of the PVQ interneurons is affected ( Figures 2D and 3B) , whereas many neurons, such as touch neurons, amphid, phasmid, and RMEV neurons display no apparent defects (Table S2) . Notably, PVQ interneurons are also affected by loss of endogenous, neuronally acting hst-6 [7] . The addition of 6O-sulfation in the wrong location (hypodermis) can therefore have the same detrimental effect for an axon as not having 6O-sulfation in the correct place (neurons). Taken together, manipulating HS modifications in the hypodermis through addition of novel HS-modification patterns can redirect axonal projections of individual neurons.
Ectopic 6O-Sulfation-Induced Motor Axon Misrouting Requires Slit/slt-1 and Its Coreceptor eva-1 Most DA/DB motor neurons that respond to ectopic HS 6O-sulfation require hst-6 also for normal development in the absence of hst-2 function (compare Figures 1E, 1F, and 3C) . The exception is DB7, suggesting that DB7 axonal projections are normally independent of 6O-sulfated HS. However, upon hst-6 expression in the hypodermis, DB7 is misrouted, suggesting that DB7 can be positively instructed by ectopic 6O-sulfated (B) Immunostaining with the AO4B08 HS-specific antibody [15] of transgenic animals, which ectopically express the HS-modification enzyme hst-6 in the hypodermis (right; otIs176). Increased hypodermal staining observed in transgenic animals is not seen in isogenic controls, which do not ectopically express hst-6 (left). Intestinal staining (not shown) serves as an internal staining control as does an unrelated synthetic antibody (MPB49), which shows no staining at all. Note that the antibody AO4B08 does not recognize individual HS modifications but rather an oligosaccharide, which requires the activities of both hst-2 and hst-6 [15] . Because only hst-2 but not hst-6 appears to be expressed in the hypodermis [7] , the observed staining of the hypodermis after misexpression of hst-6 in this tissue is consistent with the known specificities of AO4B08. Note the aberrant projection of DB6 in the hst-6-misexpressing line (red arrowhead). HS. We therefore focus our genetic analyses here on the DB7 motor neuron.
We first asked which HS core protein would bear the ectopic 6O-sulfated HS presented by the hypodermis that misdirects the DB7 motor neuron. To this end, we systematically removed the genes coding for four canonical HS core proteins in the C. elegans genome, lon-2/glypican, gpn-1/glypican, sdn-1/ syndecan, or unc-52/perlecan, respectively, and tested the effect on DB7 motor neuron projection patterns in animals expressing hst-6 in the hypodermis. We find that removal of lon-2/glypican but none of the other HS core proteins suppresses the axonal misrouting of DB7 to a level that is statistically indistinguishable from wild-type ( Figure 3E ). As lon-2/glypican normally acts in the hypodermis [10] , our data suggest that the ectopic HS structures in the hypodermis that redirect DB7 may be attached to the LON-2/glypican HS core protein.
We next sought to address how alterations in HS-modification patterns exert an impact on the DB7 motor axon guidance decision. HS may play a role in determining ligand/receptor binding specificities in vitro (reviewed in [3] ), so we reasoned that changing HS-modification patterns may reprogram the responsiveness of motor axons to defined cues. To address this possibility, we asked whether a specific axon guidance cue is required for the misrouting of individual motor axons induced by ectopic 6O-sulfation. The guidance cue slt-1/Slit is known to require different HS modifications in distinct cellular contexts in C. elegans [7] . Slit-mediated axon growth at the fly midline, and in vertebrate tissue explants, are also known to require the presence of HS, albeit of unknown modification status [16] [17] [18] . The ligand slt-1/Slit signals through sax-3/ Robo of the Robo family of guidance receptors [19] . More recently, EVA-1, a conserved transmembrane protein with extracellular domains that display similarity to sugar binding domains, has been identified as an additional Slit/SLT-1 receptor that is required for Slit/SLT-1 signaling and physically interacts with SLT-1 [20] . (E) Effect of genetic removal of HS core proteins on projection errors in DB7 motor axons as a result of ectopic hst-6 expression. Shown is the percentage of animals with defects in DB7 motor neuron projections. Statistic comparisons are made to the transgenic control. The projection pattern of DB7 in animals that misexpress hst-6 in the hypodermis and are also mutant for lon-2 is statistically indistinguishable from nontransgenic, wild-type animals. (F) Effect of removal of genes in the Slit/Robo signaling pathway on projection errors in DB7 motor axons as a result of ectopic hst-6 expression. Shown is the percentage of animals with defects in DB7 motor axon projections. Statistic comparisons are made to the transgenic control. The projection pattern of DB7 in animals that misexpress hst-6 in the hypodermis and are also mutant for slt-1 or eva-1 is statistically indistinguishable from nontransgenic, wild-type animals. Error bars denote the standard error of proportion. Statistical significance is indicated by ns, not significantly different; *p < 0.05, **p < 0.005, ***p < 0.0005 in all panels.
A B C D E F
DA/DB motor neurons and in particular DB7 do not require slt-1 or eva-1 to make their correct guidance decision at the midline while its canonical receptor sax-3/Robo is involved in routing all DA/DB motor neurons ( Figure 3D ; Figure S1B ). These findings are consistent with previous findings demonstrating that sax-3/Robo has functions that are independent of its canonical ligand slt-1/Slit [7, 19] and imply that this slt-1-independent function of sax-3/Robo is likewise independent of eva-1. Intriguingly, loss of slt-1 significantly suppresses the axonal projection defects in DB7 as a result of ectopically expressing hst-6 in the hypodermis ( Figure 3F ). This suppression does not result from changes in expression levels of either slt-1 or its canonical receptor sax-3 ( Figure S5) . Thus, a possible interpretation of our data is that ectopic 6O-sulfated HS attached to LON-2/glypican instructs SLT-1 to misroute the DB7 motor axon by possibly promoting the interaction of SLT-1 with a cognate receptor on motor neurons, thereby misrouting an extending axon.
We next asked whether the slt-1/Slit receptor eva-1 could serve as this cognate receptor in the context of DB7 misrouting. Indeed, genetic removal of eva-1 significantly suppresses the hst-6-dependent axonal misrouting of DB7 ( Figure 3F ). With eva-1 expressed in eMNs [20] , this genetic data is in accord with a scenario where HS of a specific modification status instructs slt-1 to interact with eva-1, leading to an axonal misrouting response of DB7. The misrouting of DB7 must be largely sax-3 independent because the penetrance of defects in the hst-6 misexpression strain (10.2%) and sax-3 lossof-function animals (19.8%) are additive in the strain carrying the hst-6-misexpressing transgene in conjunction with the sax-3 null mutation (34.3%) (compare Figures 3D and 3F ). This last finding implies potential sax-3-independent functions for eva-1.
Discussion
Our analysis of the projection patterns of embryonic motor axons in C. elegans reveals that superficially similar neuron types are programmed to extend their axons in distinct directions through diverse mechanisms. In addition to a large number of guidance cues and intracellular signaling molecules, which are involved in patterning motor axon projections at the worm midline (data not shown), HS modifications play a crucial role in determining the projection patterns of individual motor axons. Our findings indicate that HS modifications have specific and instructive functions, likely through mediating specific ligand/receptor interactions (Figure 4) . This interpretation takes the broadly accepted concept into account that extracellular HS molecules not only promote, but are often essential for, the activity of specific ligand/receptor systems [3] . In support of this notion, in vitro experiments suggest that differentially modified HS can promote signaling through distinct signaling systems [21, 22] . Together with our finding that both the removal of enzymes that modify HS molecules as well as the ectopic addition of HS modifications through misexpression of a HS-modifying enzyme causes misrouting defects, we propose that the local modification status of HS in the vicinity of extending motor axons impinges on which ligand/receptor system is engaged (Figure 4) . This model is consistent not only with the effects observed upon removal of HS-modifying enzymes, but also with the genetic analyses of animals with ectopic expression of hst-6 in the hypodermis. In this scenario, the introduction of a novel HS-modification pattern that is attached to a specific core protein in the hypodermis (LON-2) aberrantly promotes the interaction of the repulsive SLT-1 cue with a receptor molecule, possibly EVA-1, thereby causing a misorientation of motor axon pathfinding (Figure 4 ). This is supported by our genetic data demonstrating that genetic removal of lon-2, slt-1, or eva-1 suppresses the misrouting defect in DB7 to levels that are statistically indistinguishable from wild-type ( Figures 3D-3F ). However, we note that this model is not the only way to interpret the genetic interaction of ectopic hst-6 with lon-2, slt-1, or eva-1. Indirect effects are conceivable and can not be ruled out by genetic analysis alone.
With this caveat in mind, the finding that ectopic expression of an HS-modifying enzyme and the dependence of the resulting phenotype on a specific axon-guidance molecule (slt-1) and one of its receptors (eva-1) provides additional support for a concept in which the enormous molecular complexity embedded with HS molecules may carry not merely permissive but also instructive information content. It has been speculated before that the molecular diversity of HS molecules could provide a code that regulates the regiospecific activity of individual axon-patterning systems [3, [5] [6] [7] . Specifically, in the HS code hypothesis, regiospecific HS-modification patterns determine the responsiveness of neurons to individual ligand/receptor patterning cues. In accordance with this hypothesis, the removal of individual modifications causes highly specific nervous system-patterning defects [7, [23] [24] [25] (this study). Furthermore, we show that the removal of combinations of HS modifications uncovers cell-specific redundancies in the requirements for HS modifications (Figure 2) , indicating that the presumptive HS code may be degenerate. And lastly, as pointed out previously [13] , an important additional criterion for the existence of such a code is that HS modifications act instructively, and not merely as permissive cofactors. A genetic test to determine the difference between instructiveness and permissiveness is to ask whether a given gene not only Figure 3 . In wild-type animals, slt-1 or eva-1 is not required for DB7 neuron projections (as slt-1 and eva-1 mutants show no axonal defects; Figure 3D ), whereas sax-3 does normally have a role in DB7 axon extension ( Figure 3D ). In wild-type animals, SAX-3 may therefore be interacting with an as yet unknown ligand X. Upon introducing ectopic 6O-sulfation patterns (red hatches), an interaction of the SLT-1 protein with EVA-1 may be promoted, which supersedes the effect normally induced by SAX-3/Ligand X. We emphasize that these conclusions are based on purely genetic arguments and that more indirect mechanistic models can be envisioned that are not shown here.
displays a specific loss-of-function phenotype, but whether a gain-of-function phenotype of the gene upon misexpression can also instruct a novel phenotype [26] . Keeping in mind that these experiments provide genetic rather than biochemical evidence for the action of HS, our results clearly show that we can redirect the DB7 neuron upon misexpression of the HS 6O-sulfotransferase hst-6. We can detect the molecular correlate of this hst-6 misexpression in the hypodermis by using both an HS-specific antibody and biochemical analyses of HS disaccharides ( Figure 2B ; Figure S2 ). Moreover, we find that this novel phenotype is dependent on a specific HS core protein (lon-2/glypican) and that aberrant 6O-sulfation appears to activate slt-1 signaling through the slt-1 receptor eva-1 ( Figures 3E  and 3F ). Further biochemical studies are warranted to corroborate these genetic results and to gain mechanistic insight into how HS can misdirect axons.
Experimental Procedures
Neuroanatomical Scoring All animals were scored at 20 C in a mixed population of midlarval to adult stages. DA/DB were scored with unc-129::gfp (evIs82b) and PVQ with sra-6::gfp (oyIs14). GFP expression in the DA/DB neurons of evIs82b transgenic animals is variable in DA7, DA8, and DA9; moreover, projection patterns of DA1, DB1, and DB2 are often not easy to follow on the single-cell level and we therefore excluded these neuron types from our analysis. Individual motor neurons were identified based on their cell-body position and the dorsal projection patterns. In each figure, the error bars denote the standard error of proportion and asterisks indicate statistical significance: *p < 0.05, **p < 0.005, ***p < 0.0005; n.s., not significant. Statistical significance was calculated with the z-test. If multiple comparisons were made, p values were subjected to the Bonferroni correction.
Transgenes
For ectopic hypodermal expression of HS-modifying enzymes, the complete hst-6 and hst-2 loci were fused to the dpy-7 promoter [14] by PCR fusion [27] . For the dpy-7 prom ::hst-6 mut construct, the template for PCR fusion was genomic DNA from OH281 [mgIs18; lon-2(e678)hst-6(ot17)], which harbors a premature stop codon in hst-6 [28] . All constructs were injected at 2.5 ng/ml into evIs82b (Is[unc-129::gfp]) with pceh-22::gfp at 50 ng/ml as injection marker and pBS at 50 ng/ml as carrier.
Immunohistochemistry
Worms were prepared for immunohistochemistry with a freeze crack protocol [29] followed by 20 min fixations in ice-cold acetone and methanol, respectively. Worms were then incubated for 30 min in PBS containing 10% donkey serum and in the same buffer at 4 C overnight with antibody AO4B08 or HS4C3 (1:5) [15, 30] . The immunohistochemical stain was developed with the monoclonal anti-VSV antibody P5D4 (dilution 1:250) and Alexa-labeled (555) donkey anti-mouse antibodies (dilution 1:250).
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